PAB should be $100m market cap at time of clinical trials. yearly highs to be broken.
https://www.patrys.com/site/in-the-news/Bioshares_PAB_28Sept2020.pdf
"Patrys expects its lead compound to enter clinical studies towards the end of next year. A transaction for its lead program may occur before then."
- Forums
- ASX - By Stock
- Ann: PAB Business Review - 30 June 2020
PAB should be $100m market cap at time of clinical trials....
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $16.46M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $2.916K | 398.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3479285 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1732079 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30994 | 0.008 |
11 | 2592817 | 0.007 |
12 | 2704182 | 0.006 |
9 | 3859992 | 0.005 |
5 | 4174000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 30995 | 1 |
0.008 | 1732079 | 8 |
0.009 | 108695 | 1 |
0.010 | 306000 | 3 |
0.011 | 1780000 | 4 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online